Skip to main content
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 1989 Jan 15;140(2):125–128.

Laboratory diagnosis of the first cases of HIV-2 infection in Canada.

P W Neumann 1, M V O'Shaughnessy 1, D Lepine 1, I D'Souza 1, C Major 1, B McLaughlin 1
PMCID: PMC1268581  PMID: 2562925

Abstract

Until recently the geographic distribution of infection due to human immunodeficiency virus type 2 (HIV-2) had excluded North America. We report the first two cases of such infection in Canada. Both people came from endemic areas of western Africa and were asymptomatic. The results of a commercial enzyme immunoassay specific for HIV-1 antibody were positive in both cases, but those of the Western blot technique were indeterminate. The Western blot technique specific for HIV-2 antibody and the indirect fluorescent antibody test were used to verify the presence of HIV-2 antibody.

Full text

PDF

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Clavel F., Guétard D., Brun-Vézinet F., Chamaret S., Rey M. A., Santos-Ferreira M. O., Laurent A. G., Dauguet C., Katlama C., Rouzioux C. Isolation of a new human retrovirus from West African patients with AIDS. Science. 1986 Jul 18;233(4761):343–346. doi: 10.1126/science.2425430. [DOI] [PubMed] [Google Scholar]
  2. Clavel F., Mansinho K., Chamaret S., Guetard D., Favier V., Nina J., Santos-Ferreira M. O., Champalimaud J. L., Montagnier L. Human immunodeficiency virus type 2 infection associated with AIDS in West Africa. N Engl J Med. 1987 May 7;316(19):1180–1185. doi: 10.1056/NEJM198705073161903. [DOI] [PubMed] [Google Scholar]
  3. Denis F., Leonard G., Sangare A., Gershy-Damet G., Rey J. L., Soro B., Schmidt D., Mounier M., Verdier M., Baillou A. Comparison of 10 enzyme immunoassays for detection of antibody to human immunodeficiency virus type 2 in West African sera. J Clin Microbiol. 1988 May;26(5):1000–1004. doi: 10.1128/jcm.26.5.1000-1004.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Horsburgh C. R., Jr, Holmberg S. D. The global distribution of human immunodeficiency virus type 2 (HIV-2) infection. Transfusion. 1988 Mar-Apr;28(2):192–195. doi: 10.1046/j.1537-2995.1988.28288179031.x. [DOI] [PubMed] [Google Scholar]
  5. Marlink R. G., Ricard D., M'Boup S., Kanki P. J., Romet-Lemonne J. L., N'Doye I., Diop K., Simpson M. A., Greco F., Chou M. J. Clinical, hematologic, and immunologic cross-sectional evaluation of individuals exposed to human immunodeficiency virus type-2 (HIV-2). AIDS Res Hum Retroviruses. 1988 Apr;4(2):137–148. doi: 10.1089/aid.1988.4.137. [DOI] [PubMed] [Google Scholar]
  6. Neumann P. W., Benning B. J., Robinson D. G., Gilmore N., O'Shaughnessy M. V. HTLV-III infection in Canada in 1985. CMAJ. 1986 Sep 1;135(5):477–480. [PMC free article] [PubMed] [Google Scholar]
  7. Pan L. Z., Cheng-Mayer C., Levy J. A. Patterns of antibody response in individuals infected with the human immunodeficiency virus. J Infect Dis. 1987 Apr;155(4):626–632. doi: 10.1093/infdis/155.4.626. [DOI] [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES